Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Archer

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Obstetrics and Gynecology|November 25, 2010
Contraceptive efficacy, acceptability, and safety of C31G and nonoxynol-9 spermicidal gels: a randomized controlled trialAnne E Burke, Kurt Barnhart, Jeffrey T Jensen, et al.
Lancet (London, England)|September 18, 2022
Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trialsJacques Donnez, Hugh S Taylor, Elizabeth A Stewart, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|May 13, 2010
High internal consistency and efficacy of intravaginal DHEA for vaginal atrophyFernand Labrie, David Archer, Céline Bouchard, et al.
The Journal of Sexual Medicine|April 30, 2014
Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal womenFernand Labrie, David Archer, Céline Bouchard, et al.
Menopause (New York, N.Y.)|May 9, 2009
Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal womenFernand Labrie, David Archer, Céline Bouchard, et al.
Menopause (New York, N.Y.)|May 14, 2009
Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophyFernand Labrie, David Archer, Céline Bouchard, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2017
Ancient individuals from the North American Northwest Coast reveal 10,000 years of regional genetic continuityJohn Lindo, Alessandro Achilli, Ugo A Perego, et al.
Menopause (New York, N.Y.)|May 14, 2009
Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administrationFernand Labrie, David Archer, Céline Bouchard, et al.
Journal of Environmental Quality|June 20, 2025
Selecting performance indicators for farms and ranches engaged in collaborative agroecosystem researchMegan Donovan, Sheri Spiegal, Nicole Kaplan, et al.
JMIR Research Protocols|July 6, 2022
Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility StudyLakshmanan Krishnamurti, Staci D Arnold, Ann Haight, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Obstetrics and Gynecology|November 25, 2010
Contraceptive efficacy, acceptability, and safety of C31G and nonoxynol-9 spermicidal gels: a randomized controlled trialAnne E Burke, Kurt Barnhart, Jeffrey T Jensen, et al.
Lancet (London, England)|September 18, 2022
Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trialsJacques Donnez, Hugh S Taylor, Elizabeth A Stewart, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|May 13, 2010
High internal consistency and efficacy of intravaginal DHEA for vaginal atrophyFernand Labrie, David Archer, Céline Bouchard, et al.
The Journal of Sexual Medicine|April 30, 2014
Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal womenFernand Labrie, David Archer, Céline Bouchard, et al.
Menopause (New York, N.Y.)|May 9, 2009
Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal womenFernand Labrie, David Archer, Céline Bouchard, et al.
Menopause (New York, N.Y.)|May 14, 2009
Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophyFernand Labrie, David Archer, Céline Bouchard, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2017
Ancient individuals from the North American Northwest Coast reveal 10,000 years of regional genetic continuityJohn Lindo, Alessandro Achilli, Ugo A Perego, et al.
Menopause (New York, N.Y.)|May 14, 2009
Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administrationFernand Labrie, David Archer, Céline Bouchard, et al.
Journal of Environmental Quality|June 20, 2025
Selecting performance indicators for farms and ranches engaged in collaborative agroecosystem researchMegan Donovan, Sheri Spiegal, Nicole Kaplan, et al.
JMIR Research Protocols|July 6, 2022
Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility StudyLakshmanan Krishnamurti, Staci D Arnold, Ann Haight, et al.
Pageof 5